-
1
-
-
33846181370
-
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
-
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007;356:115-24.
-
(2007)
N Engl J Med
, vol.356
, pp. 115-124
-
-
Motzer, R.J.1
Hutson, T.E.2
Tomczak, P.3
Michaelson, M.D.4
Bukowski, R.M.5
Rixe, O.6
-
2
-
-
68949145218
-
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma
-
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Oudard S, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009;27:3584-90.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3584-3590
-
-
Motzer, R.J.1
Hutson, T.E.2
Tomczak, P.3
Michaelson, M.D.4
Bukowski, R.M.5
Oudard, S.6
-
3
-
-
37349080670
-
Bevacizumab plus interferon alfa-2a for treatment ofmetastatic renal cell carcinoma: A randomised, double-blind phase III trial
-
Escudier B, Pluzanska A, Koralewski P, Ravaud A, Bracarda S, Szczylik C, et al. Bevacizumab plus interferon alfa-2a for treatment ofmetastatic renal cell carcinoma: a randomised, double-blind phase III trial. Lancet 2007;370:2103-11.
-
(2007)
Lancet
, vol.370
, pp. 2103-2111
-
-
Escudier, B.1
Pluzanska, A.2
Koralewski, P.3
Ravaud, A.4
Bracarda, S.5
Szczylik, C.6
-
4
-
-
76249126867
-
Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma
-
Huang D, Ding Y, Li Y, Luo WM, Zhang ZF, Snider J, et al. Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma. Cancer Res 2010;70:1053-62.
-
(2010)
Cancer Res
, vol.70
, pp. 1053-1062
-
-
Huang, D.1
Ding, Y.2
Li, Y.3
Luo, W.M.4
Zhang, Z.F.5
Snider, J.6
-
5
-
-
0038293080
-
Prognostic significance of tumor oxygenation in humans
-
Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 2003;195:1-16.
-
(2003)
Cancer Lett
, vol.195
, pp. 1-16
-
-
Evans, S.M.1
Koch, C.J.2
-
6
-
-
69349097400
-
Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy
-
Ebos JM, Lee CR, Kerbel RS. Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin Cancer Res 2009;15:5020-5.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5020-5025
-
-
Ebos, J.M.1
Lee, C.R.2
Kerbel, R.S.3
-
7
-
-
84857407549
-
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
-
Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A 2012;109:2784-9.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 2784-2789
-
-
Conley, S.J.1
Gheordunescu, E.2
Kakarala, P.3
Newman, B.4
Korkaya, H.5
Heath, A.N.6
-
8
-
-
34247565990
-
Severe hypoxia defi nes heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells
-
Giuntoli S, Rovida E, Gozzini A, Barbetti V, Cipolleschi MG, Olivotto M, et al. Severe hypoxia defi nes heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. Stem Cells 2007;25: 1119-25.
-
(2007)
Stem Cells
, vol.25
, pp. 1119-1125
-
-
Giuntoli, S.1
Rovida, E.2
Gozzini, A.3
Barbetti, V.4
Cipolleschi, M.G.5
Olivotto, M.6
-
9
-
-
66149180568
-
An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells
-
Lau CK, Yang ZF, Ho DW, Ng MN, Yeoh GC, Poon RT, et al. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin Cancer Res 2009;15: 3462-71.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 3462-3471
-
-
Lau, C.K.1
Yang, Z.F.2
Ho, D.W.3
Ng, M.N.4
Yeoh, G.C.5
Poon, R.T.6
-
10
-
-
33745198035
-
Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations
-
Giuntoli S, Rovida E, Barbetti V, Cipolleschi MG, Olivotto M, Dello Sbarba P. Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML populations. Leukemia 2006;20:1291-3.
-
(2006)
Leukemia
, vol.20
, pp. 1291-1293
-
-
Giuntoli, S.1
Rovida, E.2
Barbetti, V.3
Cipolleschi, M.G.4
Olivotto, M.5
Dello Sbarba, P.6
-
11
-
-
77951498319
-
Hypoxia-driven angiogenesis: Role of tip cells and extracellular matrix scaffolding
-
Germain S, Monnot C, Muller L, Eichmann A. Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. Curr Opin Hematol 2010;17:245-51.
-
(2010)
Curr Opin Hematol
, vol.17
, pp. 245-251
-
-
Germain, S.1
Monnot, C.2
Muller, L.3
Eichmann, A.4
-
12
-
-
70449687092
-
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha
-
Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009;28:3949-59.
-
(2009)
Oncogene
, vol.28
, pp. 3949-3959
-
-
Soeda, A.1
Park, M.2
Lee, D.3
Mintz, A.4
Androutsellis-Theotokis, A.5
McKay, R.D.6
-
13
-
-
70350225829
-
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
-
Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009;8: 3274-84.
-
(2009)
Cell Cycle
, vol.8
, pp. 3274-3284
-
-
Heddleston, J.M.1
Li, Z.2
McLendon, R.E.3
Hjelmeland, A.B.4
Rich, J.N.5
-
14
-
-
85027941540
-
Hypoxiainduced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells
-
Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W, et al. Hypoxiainduced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene 2011;30:4075-86.
-
(2011)
Oncogene
, vol.30
, pp. 4075-4086
-
-
Xing, F.1
Okuda, H.2
Watabe, M.3
Kobayashi, A.4
Pai, S.K.5
Liu, W.6
-
15
-
-
33750313208
-
Cancer stem cells -perspectives on current status and future directions: AACR Workshop on cancer stem cells
-
ClarkeMF, Dick JE,Dirks PB, Eaves CJ, Jamieson CH, JonesDL, et al. Cancer stem cells -perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-44.
-
(2006)
Cancer Res
, vol.66
, pp. 9339-9344
-
-
Clarke, M.F.1
Dick, J.E.2
Dirks, P.B.3
Eaves, C.J.4
Jamieson, Ch.5
Jones, D.L.6
-
16
-
-
0031453534
-
AC133, a novel marker forhuman hematopoietic stem and progenitor cells
-
Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker forhuman hematopoietic stem and progenitor cells. Blood 1997;90:5002-12.
-
(1997)
Blood
, vol.90
, pp. 5002-5012
-
-
Yin, A.H.1
Miraglia, S.2
Zanjani, E.D.3
Almeida-Porada, G.4
Ogawa, M.5
Leary, A.G.6
-
17
-
-
13244251415
-
Isolation of renal progenitor cells from adult human kidney
-
Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, et al. Isolation of renal progenitor cells from adult human kidney. Am J Pathol 2005;166:545-55.
-
(2005)
Am J Pathol
, vol.166
, pp. 545-555
-
-
Bussolati, B.1
Bruno, S.2
Grange, C.3
Buttiglieri, S.4
Deregibus, M.C.5
Cantino, D.6
-
18
-
-
9244241576
-
Identification of human brain tumour initiating cells
-
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004;432: 396-401.
-
(2004)
Nature
, vol.432
, pp. 396-401
-
-
Singh, S.K.1
Hawkins, C.2
Clarke, I.D.3
Squire, J.A.4
Bayani, J.5
Hide, T.6
-
19
-
-
33846100356
-
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
-
O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007;445:106-10.
-
(2007)
Nature
, vol.445
, pp. 106-110
-
-
O'Brien, C.A.1
Pollett, A.2
Gallinger, S.3
Dick, J.E.4
-
20
-
-
39549122204
-
Essential but differential role forCXCR4andCXCR7 in the therapeutic homing of human renal progenitor cells
-
Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, Angelotti ML, et al. Essential but differential role forCXCR4andCXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008;205:479-90.
-
(2008)
J Exp Med
, vol.205
, pp. 479-490
-
-
Mazzinghi, B.1
Ronconi, E.2
Lazzeri, E.3
Sagrinati, C.4
Ballerini, L.5
Angelotti, M.L.6
-
21
-
-
34548455927
-
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer
-
Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1: 313-23.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 313-323
-
-
Hermann, P.C.1
Huber, S.L.2
Herrler, T.3
Aicher, A.4
Ellwart, J.W.5
Guba, M.6
-
22
-
-
79960702572
-
Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1alpha-dependent manner in pancreatic cancer cells
-
Hashimoto O, Shimizu K, Semba S, Chiba S, Ku Y, Yokozaki H, et al. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1alpha-dependent manner in pancreatic cancer cells. Pathobiology 2011;78:181-92.
-
(2011)
Pathobiology
, vol.78
, pp. 181-192
-
-
Hashimoto, O.1
Shimizu, K.2
Semba, S.3
Chiba, S.4
Ku, Y.5
Yokozaki, H.6
-
23
-
-
78649864565
-
Differential role of CD133 and CXCR4 in renal cell carcinoma
-
D'Alterio C, Cindolo L, Portella L, PolimenoM, Consales C, Riccio A, et al. Differential role of CD133 and CXCR4 in renal cell carcinoma. Cell Cycle 2010;9:4492-500.
-
(2010)
Cell Cycle
, vol.9
, pp. 4492-4500
-
-
D'Alterio, C.1
Cindolo, L.2
Portella, L.3
Polimeno, M.4
Consales, C.5
Riccio, A.6
-
24
-
-
84862619467
-
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer
-
D'Alterio C, Portella L, Ottaiano A, Rizzo M, CarteniG, Pignata S, et al.High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancer. Curr Cancer Drug Targets 2012;12:693-702.
-
(2012)
Curr Cancer Drug Targets
, vol.12
, pp. 693-702
-
-
D'Alterio, C.1
Portella, L.2
Ottaiano, A.3
Rizzo, M.4
Carteni, G.5
Pignata, S.6
-
25
-
-
54049126940
-
Identi fication of a tumor-initiating stem cell population in human renal carcinomas
-
Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G. Identi fication of a tumor-initiating stem cell population in human renal carcinomas. FASEB J 2008;22:3696-705.
-
(2008)
FASEB J
, vol.22
, pp. 3696-3705
-
-
Bussolati, B.1
Bruno, S.2
Grange, C.3
Ferrando, U.4
Camussi, G.5
-
26
-
-
79960462574
-
Endoglin (CD105): A review of its role in angiogenesis and tumor diagnosis, progression and therapy
-
Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, et al. Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 2011;31: 2283-90.
-
(2011)
Anticancer Res
, vol.31
, pp. 2283-2290
-
-
Nassiri, F.1
Cusimano, M.D.2
Scheithauer, B.W.3
Rotondo, F.4
Fazio, A.5
Yousef, G.M.6
-
27
-
-
79956101964
-
Endoglin regulates cancer-stromal cell interactions in prostate tumors
-
Romero D, O'Neill C, Terzic A, Contois L, Young K, Conley BA, et al. Endoglin regulates cancer-stromal cell interactions in prostate tumors. Cancer Res 2011;71:3482-93.
-
(2011)
Cancer Res
, vol.71
, pp. 3482-3493
-
-
Romero, D.1
O'Neill, C.2
Terzic, A.3
Contois, L.4
Young, K.5
Conley, B.A.6
-
28
-
-
70349968211
-
Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma
-
Patard JJ, Rioux-Leclercq N, Masson D, Zerrouki S, Jouan F, Collet N, et al. Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma. Br J Cancer 2009;101:1417-24.
-
(2009)
Br J Cancer
, vol.101
, pp. 1417-1424
-
-
Patard, J.J.1
Rioux-Leclercq, N.2
Masson, D.3
Zerrouki, S.4
Jouan, F.5
Collet, N.6
-
29
-
-
0033587146
-
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
-
Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999;399:271-5.
-
(1999)
Nature
, vol.399
, pp. 271-275
-
-
Maxwell, P.H.1
Wiesener, M.S.2
Chang, G.W.3
Clifford, S.C.4
Vaux, E.C.5
Cockman, M.E.6
-
30
-
-
84873091765
-
KaelinWGJr. The VHL/HIF axis in clear cell renal carcinoma
-
Shen C, KaelinWGJr. The VHL/HIF axis in clear cell renal carcinoma. Semin Cancer Biol 2013;23:18-25.
-
(2013)
Semin Cancer Biol
, vol.23
, pp. 18-25
-
-
Shen, C.1
-
31
-
-
20744445650
-
Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von hippel-lindau-associated renal cell carcinoma
-
Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol 2005;25:5675-86.
-
(2005)
Mol Cell Biol
, vol.25
, pp. 5675-5686
-
-
Raval, R.R.1
Lau, K.W.2
Tran, M.G.3
Sowter, H.M.4
Mandriota, S.J.5
Li, J.L.6
-
32
-
-
66349100709
-
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney
-
Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, et al. Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 2009;69:4674-81.
-
(2009)
Cancer Res
, vol.69
, pp. 4674-4681
-
-
Beroukhim, R.1
Brunet, J.P.2
Di Napoli, A.3
Mertz, K.D.4
Seeley, A.5
Pires, M.M.6
-
33
-
-
60649087564
-
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
-
Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 2009;15:232-9.
-
(2009)
Cancer Cell
, vol.15
, pp. 232-239
-
-
Ebos, J.M.1
Lee, C.R.2
Cruz-Munoz, W.3
Bjarnason, G.A.4
Christensen, J.G.5
Kerbel, R.S.6
-
34
-
-
60649106195
-
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
-
Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009;15: 220-31.
-
(2009)
Cancer Cell
, vol.15
, pp. 220-231
-
-
Paez-Ribes, M.1
Allen, E.2
Hudock, J.3
Takeda, T.4
Okuyama, H.5
Vinals, F.6
-
35
-
-
84923208463
-
-
Available from
-
Available from: http://www.cancer.gov/clinicaltrials/search.
-
-
-
|